Harmony Biosciences Holdings, Inc.
US ˙ NasdaqGM ˙ US4131971040

Introduction

This page provides a comprehensive analysis of the known insider trading history of John C Jacobs. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate John C Jacobs has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:NVAX / Novavax, Inc. President and CEO, Director 136,732
US:HRMY / Harmony Biosciences Holdings, Inc. PRESIDENT, CEO, Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by John C Jacobs. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases HRMY / Harmony Biosciences Holdings, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in HRMY / Harmony Biosciences Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HRMY / Harmony Biosciences Holdings, Inc. Insider Trades
Insider Sales HRMY / Harmony Biosciences Holdings, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in HRMY / Harmony Biosciences Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HRMY / Harmony Biosciences Holdings, Inc. Insider Trades
Insider Purchases NVAX / Novavax, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in HRMY / Harmony Biosciences Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NVAX / Novavax, Inc. Insider Trades
Insider Sales NVAX / Novavax, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in HRMY / Harmony Biosciences Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NVAX / Novavax, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by John C Jacobs as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-03-04 2025-03-01 4 NVAX NOVAVAX INC
Common Stock
F - Taxes -38,451 136,732 -21.95 8.33 -320,297 1,138,978
2025-03-04 2025-03-01 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 83,334 175,183 90.73
2025-01-27 2025-01-23 4 NVAX NOVAVAX INC
Common Stock
F - Taxes -38,873 91,849 -29.74 9.55 -371,237 877,158
2025-01-27 2025-01-23 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 83,196 130,722 175.05
2024-01-25 2024-01-23 4 NVAX NOVAVAX INC
Common Stock
F - Taxes -40,093 43,104 -48.19 4.26 -170,796 183,623
2024-01-25 2024-01-23 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 83,197 83,197
2022-08-16 2022-08-15 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -909 0 -100.00 51.76 -47,053
2022-08-16 2022-08-15 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -39,091 909 -97.73 51.05 -1,995,760 46,408
2022-08-16 2022-08-15 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
M - Exercise 40,000 40,000 8.22 328,800 328,800
2022-06-16 2022-06-15 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -800 0 -100.00 46.13 -36,907
2022-06-16 2022-06-15 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -14,200 800 -94.67 45.38 -644,370 36,303
2022-06-16 2022-06-15 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
M - Exercise 15,000 15,000 8.22 123,300 123,300
2022-06-14 2022-06-13 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -15,197 0 -100.00 44.53 -676,675
2022-06-14 2022-06-13 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -9,803 15,197 -39.21 43.63 -427,735 663,092
2022-06-14 2022-06-13 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
M - Exercise 25,000 25,000 8.22 205,500 205,500
2022-03-18 2022-03-16 4 HRMY Harmony Biosciences Holdings, Inc.
Stock Option
M - Exercise -15,000 194,751 -7.15
2022-03-18 2022-03-16 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -15,000 0 -100.00 45.32 -679,821
2022-03-18 2022-03-16 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
M - Exercise 15,000 15,000 8.22 123,300 123,300
2022-03-16 2022-03-14 4 HRMY Harmony Biosciences Holdings, Inc.
Stock Option
M - Exercise -25,000 209,751 -10.65
2022-03-16 2022-03-14 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -930 0 -100.00 43.47 -40,427
2022-03-16 2022-03-14 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -11,614 930 -92.59 42.66 -495,474 39,675
2022-03-16 2022-03-14 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -12,456 12,544 -49.82 42.06 -523,871 527,572
2022-03-16 2022-03-14 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
M - Exercise 25,000 25,000 8.22 205,500 205,500
2022-01-05 2022-01-04 4 HRMY Harmony Biosciences Holdings, Inc.
Stock Option
M - Exercise -18,053 234,751 -7.14
2022-01-05 2022-01-04 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -18,053 0 -100.00 45.15 -815,050
2022-01-05 2022-01-04 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
M - Exercise 18,053 18,053 8.22 148,396 148,396
2022-01-05 2022-01-03 4 HRMY Harmony Biosciences Holdings, Inc.
Stock Option
M - Exercise -10,647 252,804 -4.04
2022-01-05 2022-01-03 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -10,647 0 -100.00 45.17 -480,936
2022-01-05 2022-01-03 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
M - Exercise 10,647 10,647 8.22 87,518 87,518
2021-12-29 2021-12-27 4 HRMY Harmony Biosciences Holdings, Inc.
Stock Option
M - Exercise -1,300 263,451 -0.49
2021-12-29 2021-12-27 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -1,300 0 -100.00 45.03 -58,538
2021-12-29 2021-12-27 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
M - Exercise 1,300 1,300 8.22 10,686 10,686
2021-12-15 2021-12-13 4 HRMY Harmony Biosciences Holdings, Inc.
Stock Option
M - Exercise -25,000 264,751 -8.63
2021-12-15 2021-12-13 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -11,860 0 -100.00 38.43 -455,780
2021-12-15 2021-12-13 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -13,140 11,860 -52.56 38.02 -499,629 450,959
2021-12-15 2021-12-13 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
M - Exercise 25,000 25,000 8.22 205,500 205,500
2021-09-14 2021-09-13 4 HRMY Harmony Biosciences Holdings, Inc.
Stock Option
M - Exercise -25,000 289,751 -7.94
2021-09-14 2021-09-13 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
S - Sale X -25,000 0 -100.00 35.93 -898,262
2021-09-14 2021-09-13 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock
M - Exercise 25,000 25,000 8.22 205,500 205,500
2020-08-20 2020-08-18 4 HRMY Harmony Biosciences Holdings, Inc.
Stock Option
A - Award 144,856 144,856
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)